SEC Form 4 · accession 0001209191-19-018291
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger C Lucas
Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 8, 2019 · 7:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2019 | M | 8,421 | $0.00 | A | 102,267 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Mar 5, 2019 | M | 8,421 | D | — | — | Common Stock | 8,421 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on May 21, 2018.
- F2Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F3100% of the restricted stock units vested on March 5, 2019, the accelerated vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.